| 1 |
34200782 | Machine Learning Approaches for Predicting Bisphosphonate-Related Osteonecrosis in Women with Osteoporosis Using VEGFA Gene Polymorphisms. | 2021 Jun 10 |
2 |
| 2 |
34275224 | [Molecular mechanism of zoledronic acid inhibiting angiogenesis by semi flexible binding with vascular endothelial growth factor conformation]. | 2021 Jul 9 |
2 |
| 3 |
31445964 | Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. | 2020 Mar |
1 |
| 4 |
32276287 | Bisphosphonates inhibit surface-mediated osteogenesis. | 2020 Aug 1 |
1 |
| 5 |
26086871 | Genetic association between VEGF polymorphisms and BRONJ in the Korean population. | 2015 Oct |
2 |
| 6 |
24373581 | Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells. | 2014 Jan |
1 |
| 7 |
24636958 | Pleiotropic effects of bisphosphonates on osteosarcoma. | 2014 Jun |
1 |
| 8 |
22864527 | Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. | 2013 May |
1 |
| 9 |
23392871 | The effects of bisphosphonates on taurine transport in retinal capillary endothelial cells under high glucose conditions. | 2013 |
1 |
| 10 |
26909280 | Regulation of VEGF by mevalonate pathway inhibition in breast cancer. | 2013 Sep |
2 |
| 11 |
22986334 | Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw. | 2012 Sep 17 |
1 |
| 12 |
21251073 | Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws. | 2011 Jul |
3 |
| 13 |
19569175 | Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells. | 2010 Jan 1 |
2 |
| 14 |
21472253 | Accumulation of VEGFR2 in zoledronic acid-treated endothelial cells. | 2010 May-Jun |
1 |
| 15 |
19360288 | Examination of the mechanisms of osteolysis in patients with metastatic breast cancer. | 2009 May |
1 |
| 16 |
19398598 | Vascular endothelial growth factor activity after switching of bisphosphonate treatment for metastatic breast cancer. | 2009 May |
9 |
| 17 |
19625131 | Could local delivery of bisphosphonates be a new therapeutic choice for hemangiomas? | 2009 Oct |
1 |
| 18 |
16440584 | Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation. | 2005 |
1 |